[Inhibition of the dopamine reuptake system by analogs of the neurotoxic metabolite MPP (1-methyl-4-phenylpyridine). The structure-activity relationship].
Bachurin
S O
SO
Lukoianov
N V
NV
Petrova
L N
LN
Soliakov
L S
LS
Tkachenko
S E
SE
Raevskiĭ
O A
OA
D015655:1-Methyl-4-phenylpyridinium / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D066298:In Vitro Techniques; D051379:Mice; D013329:Structure-Activity Relationship; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism
D018765:Dopamine Uptake Inhibitors; D015655:1-Methyl-4-phenylpyridinium; D004298:Dopamine